☰

Leah M Cook - Publications

Affiliations: 
University of Nebraska Medical Center, Omaha, NE, United States 
Area:
Cancer Metastasis and Immunology
Tree Info Grants Similar researchers PubMed Report error

40 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Rajgopal S, Nakano K, Cook LM. Beyond the horizon: Neutrophils leading the way in the evolution of immunotherapy. Cancer Medicine. PMID 38062888 DOI: 10.1002/cam4.6761  0.379
2023 Alsamraae M, Costanzo-Garvey D, Teply BA, Boyle S, Sommerville G, Herbert ZT, Morrissey C, Dafferner AJ, Abdalla MY, Fallet RW, Kielian T, Jensen-Smith H, deOliveira EI, Chen K, Bettencourt IA, ... ... Cook LM, et al. Androgen receptor inhibition suppresses anti-tumor neutrophil response against bone metastatic prostate cancer via regulation of TβRI expression. Cancer Letters. 216468. PMID 37940068 DOI: 10.1016/j.canlet.2023.216468  0.453
2023 Johnson CS, Cook LM. Osteoid cell-derived chemokines drive bone-metastatic prostate cancer. Frontiers in Oncology. 13: 1100585. PMID 37025604 DOI: 10.3389/fonc.2023.1100585  0.431
2023 Bhat AM, Mohapatra BC, Luan H, Mushtaq I, Chakraborty S, Dutta S, Storck MD, Meza JL, Lin MF, Cook LM, Corey E, Morrissey C, Coulter DW, Jordan Rowley M, Datta K, et al. Role of GD2 and its biosynthetic enzyme GD3 synthase in prostate cancer tumorigenesis. Biorxiv : the Preprint Server For Biology. PMID 36993422 DOI: 10.1101/2023.03.18.533299  0.452
2022 Costanzo-Garvey DL, Case AJ, Watson GF, Alsamraae M, Chatterjee A, Oberley-Deegan RE, Dutta S, Abdalla MY, Kielian T, Lindsey ML, Cook LM. Prostate cancer addiction to oxidative stress defines sensitivity to anti-tumor neutrophils. Clinical & Experimental Metastasis. PMID 35604506 DOI: 10.1007/s10585-022-10170-x  0.447
2021 Alsamraae M, Cook LM. Emerging roles for myeloid immune cells in bone metastasis. Cancer Metastasis Reviews. PMID 33855680 DOI: 10.1007/s10555-021-09965-3  0.387
2021 McGuire JJ, Frieling JS, Lo CH, Li T, Muhammad A, Lawrence HR, Lawrence NJ, Cook LM, Lynch CC. Mesenchymal stem cell-derived interleukin-28 drives the selection of apoptosis resistant bone metastatic prostate cancer. Nature Communications. 12: 723. PMID 33526787 DOI: 10.1038/s41467-021-20962-6  0.395
2020 Costanzo-Garvey DL, Keeley T, Case AJ, Watson GF, Alsamraae M, Yu Y, Su K, Heim CE, Kielian T, Morrissey C, Frieling JS, Cook LM. Neutrophils are mediators of metastatic prostate cancer progression in bone. Cancer Immunology, Immunotherapy : Cii. PMID 32114681 DOI: 10.1007/S00262-020-02527-6  0.503
2019 Keeley T, Costanzo-Garvey DL, Cook LM. Unmasking the Many Faces of Tumor-Associated Neutrophils and Macrophages: Considerations for Targeting Innate Immune Cells in Cancer. Trends in Cancer. 5: 789-798. PMID 31813456 DOI: 10.1016/J.Trecan.2019.10.013  0.469
2019 Cook LM, Frieling JS, Nerlakanti N, McGuire JJ, Stewart PA, Burger KL, Cleveland JL, Lynch CC. Betaglycan drives the mesenchymal stromal cell osteogenic program and prostate cancer-induced osteogenesis. Oncogene. PMID 31409900 DOI: 10.1038/S41388-019-0913-4  0.518
2019 Mcguire JJ, Cook L, Frieling J, Muhammad A, Lawrence H, Lawrence N, Lynch C. Abstract 1992: Mesenchymal stem cell-derived interleukin-28 can drive the selection of apoptosis resistant bone metastatic prostate cancer Cancer Research. 79: 1992-1992. DOI: 10.1158/1538-7445.Am2019-1992  0.534
2019 Cook LM, Costanzo-Garvey D, Keeley T. Abstract 1087: Bone-resident neutrophils are mediators of prostate cancer growth in bone Cancer Research. 79: 1087-1087. DOI: 10.1158/1538-7445.Am2019-1087  0.555
2018 Khadge S, Sharp JG, McGuire TR, Thiele GM, Black P, DiRusso C, Cook L, Klassen LW, Talmadge JE. Immune regulation and anti-cancer activity by lipid inflammatory mediators. International Immunopharmacology. 65: 580-592. PMID 30447537 DOI: 10.1016/J.Intimp.2018.10.026  0.388
2018 Khadge S, Thiele GM, Sharp JG, McGuire TR, Klassen LW, Black PN, DiRusso CC, Cook L, Talmadge JE. Long-chain omega-3 polyunsaturated fatty acids decrease mammary tumor growth, multiorgan metastasis and enhance survival. Clinical & Experimental Metastasis. PMID 30327985 DOI: 10.1007/S10585-018-9941-7  0.454
2018 Araujo A, Cook LM, Lynch CC, Basanta D. Size Matters: Metastatic Cluster Size and Stromal Recruitment in the Establishment of Successful Prostate Cancer to Bone Metastases. Bulletin of Mathematical Biology. PMID 29600344 DOI: 10.1007/S11538-018-0416-4  0.528
2017 Cook L, Araujo A, Pow-Sang J, Budzevich M, Basanta D, Lynch CC. Abstract A13: Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Epso16-A13  0.436
2016 Cook LM, Araujo A, Pow-Sang JM, Budzevich MM, Basanta D, Lynch CC. Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer. Scientific Reports. 6: 29384. PMID 27411810 DOI: 10.1038/Srep29384  0.511
2016 McGuire J, Cook L, Frieling J, Lynch C. Abstract C18: Mesenchymal stem cells in the prostate cancer-bone microenvironment increase osteogenesis and generate apoptotic resistant cancer cells Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-C18  0.54
2016 Cook LM, McGuire JJ, Lynch CC. Abstract 749: Betaglycan-mediated regulation of mesenchymal stromal cell behavior in the prostate tumor-bone microenvironment Cancer Research. 76: 749-749. DOI: 10.1158/1538-7445.Am2016-749  0.555
2015 Gupta S, Gallaher J, Lynch C, Cook L, Araujo A, Scott J, Dhillon J, Pow-Sang J, Basanta D. Optimizing personalized treatment sequences in metastatic castration resistant prostate cancer using tumor-biomarker based computational modeling. Journal of Clinical Oncology. 33: e16014-e16014. DOI: 10.1200/Jco.2015.33.15_Suppl.E16014  0.395
2015 McGuire JJ, Cook L, Frieling J, Lynch C. Abstract 5072: Mesenchymal stem cells promote osteogenesis and the evolution of apoptosis resistant bone metastatic prostate cancer Cancer Research. 75: 5072-5072. DOI: 10.1158/1538-7445.Am2015-5072  0.533
2015 Cook LM, Araujo A, Basanta D, Lynch CC. Abstract 3751: Defining the temporal effects of TGFβ inhibition on the cellular heterogeneity of the bone metastatic prostate cancer microenvironment Cancer Research. 75: 3751-3751. DOI: 10.1158/1538-7445.Am2015-3751  0.569
2014 Gallaher J, Cook LM, Gupta S, Araujo A, Dhillon J, Park JY, Scott JG, Pow-Sang J, Basanta D, Lynch CC. Improving treatment strategies for patients with metastatic castrate resistant prostate cancer through personalized computational modeling. Clinical & Experimental Metastasis. 31: 991-9. PMID 25173680 DOI: 10.1007/S10585-014-9674-1  0.416
2014 Araujo A, Cook LM, Lynch CC, Basanta D. An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer. Cancer Research. 74: 2391-401. PMID 24788098 DOI: 10.1158/0008-5472.Can-13-2652  0.487
2014 Cook LM, Shay G, Aruajo A, Lynch CC. Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases Cancer and Metastasis Reviews. 33: 511-525. PMID 24414228 DOI: 10.1007/S10555-014-9494-4  0.466
2014 Cook LM, Araujo A, Basanta D, Lynch CC. Abstract 5330: Defining the role of TGFB in osteogenic prostate cancer to bone metastases: An integrated biological/mathematical modeling approach Cancer Research. 74: 5330-5330. DOI: 10.1158/1538-7445.Am2014-5330  0.53
2014 Mcguire JJ, Shay G, Cook L, Frieling J, Lynch C. Abstract 3595: Mesenchymal stem cells play crucial roles in the generation of osteogenic prostate to bone metastases Cancer Research. 74: 3595-3595. DOI: 10.1158/1538-7445.Am2014-3595  0.55
2014 Cook LM, Shay G, Araujo A, Lynch CC. Erratum to: Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases Cancer and Metastasis Reviews. 33: 1125-1125. DOI: 10.1007/S10555-014-9507-3  0.376
2013 Cook L. Mesenchymal stem cells: the truth about their nature, origin and potential use for therapy Postdoc Journal. DOI: 10.14304/Surya.Jpr.V1N9.4  0.386
2013 Frieling JS, Pamen LA, Cook LM, Yang S, Lynch CC. Abstract 5061: Roles for matrix metalloproteinase-3 (MMP-3) in the prostate tumor-bone microenvironment. Cancer Research. 73: 5061-5061. DOI: 10.1158/1538-7445.Am2013-5061  0.504
2013 Cook LM, Araujo A, Basanta D, Lynch CC. Abstract 4092: Identifying the role of TGFβ in osteogenic prostate cancer to bone metastases; an integrated biological/mathematical modeling study. Cancer Research. 73: 4092-4092. DOI: 10.1158/1538-7445.Am2013-4092  0.563
2012 Cook LM, Cao X, Dowell AE, Debies MT, Edmonds MD, Beck BH, Kesterson RA, Desmond RA, Frost AR, Hurst DR, Welch DR. Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis. Clinical & Experimental Metastasis. 29: 315-25. PMID 22241150 DOI: 10.1007/S10585-012-9452-X  0.701
2012 Cook LM, Cao X, Dowell AE, Frost AA, Desmond RA, Edmonds MD, Kesterson RA, Hurst DR, Welch DR. Abstract 3416: Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis Cancer Research. 72: 3416-3416. DOI: 10.1158/1538-7445.Am2012-3416  0.704
2011 Bodenstine TM, Beck BH, Cao X, Cook LM, Ismail A, Powers SJ, Powers JK, Mastro AM, Welch DR. Pre-osteoblastic MC3T3-E1 cells promote breast cancer growth in bone in a murine xenograft model. Chinese Journal of Cancer. 30: 189-96. PMID 21352696 DOI: 10.5732/Cjc.010.10582  0.653
2011 Cook LM, Hurst DR, Welch DR. Metastasis suppressors and the tumor microenvironment. Seminars in Cancer Biology. 21: 113-22. PMID 21168504 DOI: 10.1016/J.Semcancer.2010.12.005  0.609
2010 Bodenstine TM, Vaidya KS, Ismail A, Beck BH, Cook LM, Diers AR, Landar A, Welch DR. Homotypic gap junctional communication associated with metastasis suppression increases with PKA activity and is unaffected by PI3K inhibition. Cancer Research. 70: 10002-11. PMID 21098703 DOI: 10.1158/0008-5472.Can-10-2606  0.599
2010 Yuan K, Frolova N, Xie Y, Wang D, Cook L, Kwon YJ, Steg AD, Serra R, Frost AR. Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 58: 857-70. PMID 20530462 DOI: 10.1369/Jhc.2010.955856  0.458
2010 Bodenstine TM, Vaidya KS, Ismail A, Cook LM, Welch DR. Abstract 1057: BRMS1 restoration of gap junctional intercellular communication involves modulation of KATPchannels and downregulation of phosphoinositide 3-kinase (PI3K) Cancer Research. 70: 1057-1057. DOI: 10.1158/1538-7445.Am10-1057  0.665
2009 Harper CE, Cook LM, Patel BB, Wang J, Eltoum IA, Arabshahi A, Shirai T, Lamartiniere CA. Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats. The Prostate. 69: 1668-82. PMID 19670229 DOI: 10.1002/Pros.21017  0.439
2009 Harper CE, Patel BB, Cook LM, Wang J, Shirai T, Eltoum IA, Lamartiniere CA. Characterization of SV-40 Tag rats as a model to study prostate cancer. Bmc Cancer. 9: 30. PMID 19171036 DOI: 10.1186/1471-2407-9-30  0.438
Show low-probability matches.